AEON Biopharma, Inc 8-K, filed Aug 22, 2022
AEON Biopharma, Inc. (AEON)
About this 8-K
AEON Biopharma, Inc filed this 8-K on August 22, 2022, reporting on events of August 19, 2022.
Items reported
- Item 5.03: Charter or bylaw amendment, or fiscal year change
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13
or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State
or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: +1 (
| N/A |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Title of each class | Trading Symbol(s) | Name
of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year |
On August 19, 2022, Priveterra Acquisition Corp. (the “Company”) filed a Certificate of Correction to its Second Amended and Restated Certificate of Incorporation (the “A&R Certificate) filed with the Secretary of State of the State of Delaware on February 8, 2021. The A&R Certificate inadvertently referred to a deadline of 18 months for the Company to complete its initial business combination. The Certificate of Correction corrects this scrivener’s error to the A&R Certificate and instead references a 24 month deadline. The correction made by the Certificate of Correction is retroactively effective as of February 8, 2021. The foregoing description of the Certificate of Correction is qualified in its entirety by reference to the full text of the Certificate of Correction attached as Exhibit 3.1 hereto.
| Item 9.01 | Financial Statements and Exhibits |
Exhibit No.
104 Cover Page Interactive Data File (formatted in Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 19, 2022
| PRIVETERRA ACQUISITION CORP. | ||
| By: | /s/ Oleg Grodnensky | |
| Name: | Oleg Grodnensky | |
| Title: | Chief Financial Officer | |
Exhibit 3.1
CERTIFICATE OF CORRECTION
OF
SECOND AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION
OF
PRIVETERRA ACQUISITION CORP.
Pursuant to the provisions of § 103(f) of
the General
Corporation Law of the State of Delaware
FIRST: The name of the corporation is Priveterra Acquisition Corp. (the “Corporation“).
SECOND: The Second Amended and Restated Certificate of Incorporation of the Corporation was filed in the office of the Secretary of State of the State of Delaware on February 8, 2021.
THIRD: The Second Amended and Restated Certificate of Incorporation of the Corporation so filed is an inaccurate record of the corporate action therein in that references to a deadline of 18 months throughout Article 9 are incorrect due to a scrivener’s error.
FOURTH: All references in the Second Amended and Restated Certificate of Incorporation to “18 months” are corrected to read “24 months”.
IN WITNESS WHEREOF, the undersigned has executed this Certificate of Correction this 19th day of August, 2022.
| PRIVETERRA ACQUISITION CORP. | |||
| By: | /s/ Oleg Grodnensky | ||
| Name: | Oleg Grodnensky | ||
| Title: | Chief Financial Officer | ||